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Diabetes and depression comorbidity and socio-
economic status in low and middle income countries 
(LMICs): a mapping of the evidence 
Abstract 
Non-communicable diseases account for more than 50% of deaths in adults aged 15–59 years 
in most low income countries. Depression and diabetes carry an enormous public health 
burden, making the identification of risk factors for these disorders an important strategy. 
While socio-economic inequalities in chronic diseases and their risk factors have been studied 
extensively in high-income countries, very few studies have investigated social inequalities in 
chronic disease risk factors in low or middle-income countries. Documenting chronic disease 
risk factors is important for understanding disease burdens in poorer countries and for 
targeting specific populations for the most effective interventions. The aim of this review is 
to systematically map the evidence for the association of socio-economic status with diabetes 
and depression comorbidity in low and middle income countries. The objective is to identify 
whether there is any evidence on the direction of the relationship: do co-morbidities have an 
impact on socio-economic status or vice versa and whether the prevalence of diabetes 
combined with depression is associated with socio-economic status factors within the general 
population. To date no other study has reviewed the evidence for the extent and nature of this 
relationship. By systematically mapping the evidence in the broader sense we can identify the 
policy and interventions implications of existing research, highlight the gaps in knowledge 
and suggest future research. Only 14 studies were found to analyse the associations between 
depression and diabetes comorbidity and socio-economic status. Studies show some evidence 
that the occurrence of depression among people with diabetes is associated with lower socio-
economic status. The small evidence base that considers diabetes and depression in low and 
middle income countries is out of step with the scale of the burden of disease. 
Background 
Global burden of diabetes, depression and comorbidities 
Diabetes causes 4.6 million deaths per year, accounting for 8.2% of global all-cause 
mortality, and it is estimated that 366 million adults have diabetes [1]. The global mortality 
burden of diabetes is not evenly distributed, with low and middle income countries carrying a 
disproportionate burden. It is projected that by 2030 around 82.5% of people with diabetes 
will live in developing countries [1]. The age distribution of adults with diabetes differs by 
country.
Table 1 Studies (n=14) included in the mapping 
Author Year of 
publication 
Sample 
size 
Country of 
study 
Association with SES Recommended intervention Clinical 
assessment 
Analysis 
Agbir 2010 160 Nigeria No significant association between 
patients with diabetes and depression 
and SES 
Screen people with diabetes for 
depression especially those at 
“high risk” (e.g.: unmarried 
females); increase patient 
compliance to treatment, prevent 
complications, improve quality of 
life. 
Clinical 
assessment of 
depression and 
blood glucose 
Association of depression with 
newly diagnosed type 2 
diabetes among adults 
Eren 2008 108 Turkey Negative correlation with SES 
(education) 
Early detection and treatment of 
depression in people with 
diabetes. 
Clinical 
assessment of 
depression and 
blood glucose 
Impact of depression on 
diabetic quality of life. 
James 2010 400 Nigeria SES(Education, occupation, income) Screening for depression among 
people with diabetes and 
management of depression to 
improve quality of life and reduce 
treatment costs 
Questionnaire 
and blood 
glucose 
Prevalence of depression and 
SES 
Kilzieh 2008 2038 Syria Comorbidity decreases with 
increasing SES 
Deliver treatment for depression 
in primary care settings because 
access to mental health services 
are limited and stigmatised. 
Questionnaire 
and diabetes self-
reported 
assess the comorbidity and 
correlates of depression in 
chronic diseases in a 
community 
Mansour 2007 103, 103 Iraq SES(Education, occupation, income) None made Questionnaire 
and blood 
glucose 
Determine the prevalence of 
comorbid depression among 
sample of patients with type 2 
diabetes mellitus. Control for 
social class 
Mier 2008 200 Mexico 
and USA 
Low education increases risk of 
depression 
Depression screening among 
diabetic patients by family 
practice physicians. 
Questionnaire 
and diabetes self-
reported 
prevalence and correlates of 
clinical depressive symptoms 
in Hispanics of Mexican origin 
with type 2 diabetes 
Pan 2008 3285 China Low education level and presence of 
co-morbidities associated with 
depressive symptoms 
None made Questionnaire 
and blood 
glucose 
Association between insulin 
resistance and depressive 
symptoms 
Raval 2010 300 India Relationship between comorbidity 
and income and education unclear 
None made Questionnaire 
and blood 
glucose 
Prevalence and determinants of 
depression in patients with 
established type 2 diabetes 
(T2DM) 
Sevincok 2001 98 Turkey Failed to find association between None made Clinical 
assessment and 
blood glucose 
Assess association of socio-
demographic variables for 
patients with and without 
comorbidity 
Tellez-
Zenteno 
2002 189 Mexico Higher risk of depression for lower 
SES 
Screen for depression in all 
diabetic patients, so that early 
diagnosis and treatment can 
improve patient metabolic control 
and enhance patient quality of 
life. 
Clinical 
assessment and 
blood glucose 
Identify the prevalence and 
factors associated with 
depression in a group of 
patients with type 2 diabetes 
mellitus 
Thaneerat 2009 250 Thailand Association for co-morbid patients 
not clear 
Early detection of depression 
among diabetic patients 
self-reported 
questionnaire and 
blood glucose 
To estimate the prevalence of 
depression, and poor glycemic 
control, and to determine the 
associated factors in 
outpatients with type-2 
diabetes. 
Yang 2009 148 China Not clear Early detection and treatment of 
depression in people with diabetes 
by community nurses and 
provision of social support. 
Self-reported 
Questionnaire 
and diabetes self-
reported 
To examine levels of perceived 
social support and depression 
and to identify the related 
factors and 
Yekta 2010 295 Iran Lower educated higher risk of 
depression 
None made Self-reported 
questionnaire and 
blood glucose 
taken 
To describe the prevalence of 
depression in patients 
attending a diabetes clinic 
determine the associated 
sociodemographic, behavioural 
and clinical factors. 
Zhang 
CX 
2008 304 China Not clear Identify source of patient stress; 
Advise on active coping styles; 
Mobilize more social support 
resources to reduce risk of 
depression in Type 2 diabetes. 
Clinical 
assessment and 
blood glucose 
To investigate association of 
psychosocial factors with 
anxiety and depressive 
symptoms in type 2 diabetes 
patients 
Depression is responsible for the greatest proportion of disease burden associated with non-fatal health outcomes, accounting for approximately 
12% of the total years lived with disability [2]. The evidence base and data for LICs are under-developed, but it is estimated that the average 
lifetime and 12-month prevalence estimates of Major Depression Episodes was 11.1% and 5.9%, respectively, on the basis of data from eight 
LMICs [3]. 
The occurrence of depression appears to be linked with the occurrence of diabetes. In 1684, 
Thomas Willis, the physician who first identified glycosuria as a sign of diabetes, suggested 
that diabetes resulted from ‘sadness or long sorrow and other depressions or disorders’[4]. 
Further studies have demonstrated that a comorbid state of depression incrementally worsens 
health compared with depression alone [5]. According to the latest global burden of disease 
estimates unipolar depressive disorder are third in the ranking (65.5 mil DALY worldwide of 
which 26.5 in LICs). Unipolar depressive disorders are set to become the leading disease in 
2030 with 6.3% of the overall burden and Diabetes the 10th place with 2.3% as a percentage 
of the overall DALYs [2]. 
Comorbidity has various definitions and previous literature has highlighted the difficulty of 
defining it but in general, in medicine, it is usually considered as the presence of one or more 
disorders (in addition to a primary disease or disorder), or also the effect of such additional 
disorders or diseases [6]. In this study we look at the co-presence of diabetes and depression 
regardless of whether diabetes or depression is the primary disorder. The identification of co-
morbidities is fundamental in order to understand whether the primary disorder or disease 
might either cause or affect the secondary one but also to understand any association between 
the two. 
Studies have scrutinized the association of diabetes with depression and the bidirectional 
nature of this relationship; considering that depression may occur as a consequence of having 
diabetes, but may also be a risk factor for the onset of type 2 diabetes [7-9]. One study 
showed how there is a higher risk of mood and anxiety disorders among individuals with 
diabetes relative to those without, with an odds ratio for depression of 1.38 (95% CI 1.14-
1.66) after adjusting for age and gender [10]. A meta-analysis concluded that the presence of 
diabetes doubles the odds of comorbid depression and the prevalence of comorbid depression 
among people with diabetes was 11% [11]. Estimates of depression prevalence among people 
with diabetes appear to vary by diabetes type and between lower and higher income 
countries, although the evidence base for lower income countries is much smaller than that 
for HICs [12]. A study conducted in 2007 which looked at depression worldwide using the 
WHO World Health Survey (WHS) found that 9.3% of people with depression were also 
with diabetes [5]. 
Two hypotheses attempt to explain the causal pathway between diabetes and depression. One 
hypothesis asserts that depression precedes type 2 diabetes, with depression occurring as a 
result of increased counter regulatory hormone release and action, alterations in glucose 
transport function and increased immuno-inflammatory activation. These physiologic 
alterations are thought to contribute to insulin resistance and beta islet cell dysfunction, 
leading to development of type 2 diabetes [13]. The second hypothesis is that depression in 
patients with both type 1 and type 2 diabetes results from chronic psychosocial stressors of 
having a chronic medical condition [14]. 
Evidence from HICs suggests that depression among people with diabetes is associated with 
socio-economic status [15], marital status [16], and physical activity and chronic somatic 
diseases [17]. Psychosocial factors may mediate the relation between SES and depression in 
people with diabetes, including social isolation or social support, coping styles, behaviour 
and job stress or strain [18, 19]. Most studies show inverse social gradients, meaning that the 
risk is higher for people with lower SES [15-17, 20]. However, the relationship may vary 
depending on the social and economic context of the country. In LICs, higher SES may be 
associated with higher levels of chronic disease risk factors in general [21] while the poor 
experience a double burden of infectious and chronic diseases according to the protracted 
polarised model of epidemiological transition [22]. 
In addition, the burden of risk factors for depression among people with diabetes in particular 
has been found to shift towards the less affluent in countries undergoing the epidemiologic 
transition where the cause of deaths shifts from infectious to non-infectious causes [23]. 
The aim of this systematic mapping is to identify the socio-economic factors associated with 
diabetes and depression as a comorbid condition exclusively in low and middle income 
countries. 
Methodology 
We systematically mapped the evidence pertaining to poverty and depression-diabetes 
comorbidity in low and middle income countries. We searched 12 databases, selected for 
their coverage of the behavioural and social sciences, using combinations of keywords 
(diabetes, diabetes mellitus, chronic disease, depression, depressive disorder), and individual 
countries defined as low or middle income. The search included items written in English and 
with an abstract dated 1990–2011 and was completed in August 2011. Studies were also 
identified by hand-searching reference lists of reviews and articles found in the database 
search. We used broad search terms in order to include the widest literature possible in our 
mapping. This means that we not only identified items where the authors had measured or 
defined SES, but we also included items which considered variables often used as proxies for 
SES (e.g.: education, unemployment). The search was limited to studies published after 1989 
and we identified 1747 relevant articles (Table1). 
Table 1  
Systematic mapping is a transparent technique for describing the research evidence on a 
topic. It not only allows us to take stock of the available research, but also to identify the gaps 
in the evidence base and how it might be developed [24]. The methodology for systematic 
mapping developed from work at the EPPI-Centre (Evidence for Policy and Practice 
Information and Co-ordinating Centre) and is being increasingly used in a range of social 
sciences [25-28]. The type of evidence and scope included in a systematic mapping is broader 
than that normally included in a systematic review, reflected in the breadth of the research 
questions. A systematic mapping can be much more inclusive [25–28] in its selection of 
studies than a systematic review can be. Inclusivity benefits the evidence base by assembling 
evidence in a systematic way. As a systematic mapping, rather than a systematic review, we 
have not assessed the quality of the included studies. This means that the evidence base that 
we have identified is not necessarily all of high quality. 
Inclusion and exclusion criteria 
Abstracts were screened and items included if they addressed diabetes (type 2 or type 1 and 2 
together to keep the disease type homogeneous), and depression as a comorbidity with 
diabetes, and SES. Studies were excluded if: they were conducted exclusively in HICs; did 
not address SES as a risk factor or consequence; the full-text was not in English; the study 
population was aged below 16 years; and, if there was no abstract. 
Defining and measuring SES 
Our search strategy was deliberately inclusive in order to map the available evidence as 
widely as possible. Reflecting the different approaches to conceptualising socio-economic 
status are the indicators used to measure it. Rather than considering just one term such as 
"poverty”, we considered socio-economic status (SES) in general, including both individual-
level (e.g.: education, occupation, income, household assets, place of residence, age, marital 
status, family type and social support) and household-, family- and community-level 
characteristics. Debates about conceptualising, defining and operationalizing socio-economic 
status are well-established and beyond the scope of this systematic mapping [29-34]. 
Characteristics of communities or neighbourhoods, such as the availability and accessibility 
of health services, infrastructure deprivation, prevailing attitudes towards health, levels of 
stress and social support, and environmental conditions, may influence general health 
outcomes [35]. The socio-economic status of a community may determine the educational, 
employment, and income opportunities of individuals and may also directly influence the 
social environment, although it is subject to the ‘ecological fallacy’ of assuming that all 
individuals in an area have similar characteristics [36]. 
Defining and assessing depression and diabetes 
Measurement of depression usually relies on structured interviews conducted by a 
professionally trained clinician or nursing staff using established criteria to identify a cluster 
of symptoms that may accompany depression (e.g.: loss of interest or pleasure in everyday 
activities, lack of appetite, fatigue, sleep disturbances, suicidal ideation). Most tools used to 
identify and rate the severity of depression rely on a multiple choice questionnaire (for 
example, The Hamilton Rating Scale for Depression (HRSD, HAM-D) the MINI 
questionnaire, the Beck Depression Inventory (BDI) [37]. It should be noted, however, that in 
many LICs lack the resources – both human and financial – to detect depression [38]. 
Similar problems of detection and diagnosis affect the valid measurement of diabetes in LICs 
Diabetes can be identified by either clinical blood glucose measurements, although some 
studies use ”self-reported diagnosis” associated with diabetes. Self reports of diagnosis tend 
to be used in settings where glucose data are unavailable, and cannot distinguish between 
Type 1 and Type 2 diabetes. It is important to note that self-report might underestimate type 2 
diabetes due to undiagnosed cases [12]. 
Results 
The search yielded 1,747 items, of which 1647 were excluded after abstract screening. Of the 
remaining 100 items, the full text via institutional (London School of Economics) access was 
only available for 63 studies, of which a further 11 were excluded because the full-text was 
not in English. Where full-text institutional access was not available, we used secondary 
databases (e.g.: Google Scholar) to try to retrieve full text of the remaining 37 items but none 
were available through this route. Most non-retrievable items were unpublished working 
papers with abstracts that were identified by the search, but not available electronically. The 
remaining 52 items were screened for inclusion on the basis of a review of their full text, after 
which a total of just 14 studies were selected for inclusion in the mapping. The main reason 
for exclusion at this stage was that an association between depression-diabetes comorbidity 
and SES was not sought or diabetes and depression cases were considered as separate 
diseases in two different populations rather than as a comorbidity (e.g.: diabetic patients with 
depression or viceversa) in a specific group of people. 
Description of included studies 
All the 14 included studies were published post-2007, reflecting the nascent interest in 
depression-diabetes comorbidity in LICs. All of the included studies were cross sectional in 
design, and we did not identify any longitudinal or intervention studies, meaning that causal 
inference was not a possibility in our mapping. Just five studies [39-43] used a control case 
design to compare diabetic patients with and without depression. Three studies were 
community-based [43-45] while the rest where facility-based. It is important to separate 
facility- and community-based studies in order to take account of bias (Berkson’s bias), as 
barriers to accessing health care might bias results from facility based studies because they 
are more likely to include patients: from higher socio-economic strata; with more advanced 
disease; and, more likely to have another comorbid disorder than those in the general 
population [46]. 
Facility-based studies tended to have relatively small (at most n=400) sample sizes and were 
carried out at tertiary hospitals, which in LICs might be more likely to cater for patients from 
higher socio-economic strata and with more advanced disease. This difference needs to be 
taken into account when making statements about true population differences, which might 
account for inconsistencies in association between socio-economic status and diabetes-
depression comorbidity across studies. Studies which used control groups for comparison 
where not always clear about the characteristics of the control groups which could have 
potentially affected the effect of sample sizes on the overall results. 
Of the facility-based (n=11) studies, 4 studies had a control group, although they differed in 
control group selection [39-41, 43, 47]. A study from Nigeria recruited diabetic patients as 
cases and apparently healthy controls without a history of diabetes mellitus from local 
government staff of three local government areas [40]. A similar approach was used in a 
study from Iraq, which compared diabetic patients (case) with healthy controls drawn from 
hospital staff [41]. A study conducted in Turkey recruited diabetic patients and assessed them 
for presence of depression [39]. Finally, [42] assessed the prevalence of depression in 
Hispanics of Mexican origin with type 2 diabetes living on both sides of the Texas-Mexico 
border, recruiting people with type 2 diabetes from clinical settings which included hospitals 
and physicians’ offices on both sides of the border. 
Assessing socio-economic status 
The operationalization and definition of SES in studies included in our mapping are 
heterogeneous. There is little or no discussion about the validity or reliability of the many 
difference measures of, and proxies for, SES. Studies that cautiously and robustly identify the 
presence of diabetes and depression comorbidity tend not to apply to same rigour to SES and 
its measurement. SES indicators in studies included in our mapping include indicators at a 
variety of scales, including individual and household. 
Employment and education were the most frequently used variables to assess SES. Most 
studies included education as a proxy of SES [39-42, 48-53]. Categorisations varied from 
literate-illiterate dichotomy [48, 52] to years of education [40, 50, 51]. Employment was 
considered as a dichotomy (employed vs. unemployed) [40, 48]. Three studies used income 
[40, 41, 52], and just one study used place of residence [52] to represent SES. 
Finally, three studies used composite indicators of SES [44, 53-55]. For example, a study 
from Syria assigned a score for SES based on work status, number of earning members 
within a household, household income, education level, item ownership and household 
density (number of individuals living in the household divided by the number of rooms) [44]. 
Studying comorbidities: diabetes and depression 
No study sought a causal relationship between SES and diabetes-depression comorbidity. The 
majority of studies considered the risk of, and risk factors for, depression in diabetic patients. 
Two community-based studies addressed diabetes and depression as a comorbidity – 
hereafter referred to as “direct diagnosis of comorbidity” [44, 45]. The Kilzieh study [44] 
assessed the comorbidity of depression with other chronic diseases in a single Syrian city, 
using two stage, stratified cluster sampling, with a sample size of 2038. The second study, 
from China, was community based and conducted among people with type 2 diabetes 
(n=148) and assessed the association between diabetes and depression comorbidity with SES 
[45]. 
The remaining studies looked at depression risk in patients with diabetes, hereafter referred to 
as “indirect diagnosis of comorbidity” because the comorbidity was assessed indirectly by 
considering the patient’s risk of depression. A notable finding, which helps to explain the 
lack of studies in the area of diabetes and depression comorbidity, is that in studies conducted 
at geriatric or diabetic clinics where patients came for treatment of chronic medical 
conditions, patients were often diagnosed with psychiatric comorbidity only as a result of 
going to the clinic. This suggests that there is a substantial burden of undiagnosed psychiatric 
disorders, including depression [48, 50, 51, 53, 54, 56]. 
Direct diagnosis of Comorbidities and their relationship with SES 
The study by Kilzieh [44] in Syria showed that depression comorbidity with any chronic 
disease decreased with higher SES (middle vs. low: OR=0.41, 95% CI:0.22-0.78; high vs. 
low: OR=0.52, 95% CI:0). An increase in comorbid depression in women with lower SES 
underlines the higher vulnerability of women to adverse mental health effects of lower SES. 
This relationship was not, however, confirmed in the relationship with education where a 
significant increase in depression comorbidity was reported in those with 1–9 years of 
education, which, according to the authors, may reflect ascertainment bias. That is, more 
educated individuals are more likely to seek medical care and consequently to be diagnosed 
with depression and chronic disease. This study also considered other proxies for SES, 
including the community-level proxy of place of residence, and found depression to be 
associated with disadvantaged neighbourhoods or “informal zones” (OR=0.22, 95% CI:0.06-
0.80) in the Kilzieh study [44]. Informal zones are areas in which houses were built without 
government approval, reflecting disadvantaged status. 
Unemployment was significantly associated with depression in diabetic patients in the study 
by Yang [45]. At household levels, those with low income, less wealthy or those with fewer 
household assets were more likely to be depressed [44]. Finally, lower levels of social 
support were significantly associated with depression in the study by Yang [45] using a 
multidimensional scale of perceived social support. 
Indirect diagnosis of comorbidity and its relationship with SES 
Socio-economic indicators at the individual level (e.g.: unemployment, education) were 
associated with depression in these studies that indirectly diagnosed depression-diabetes 
comorbidity [23, 45, 57]. 
A study from China found no significant difference in depressive symptoms between rural 
and urban dwellers (p=0.129) [49]. This study was conducted in one rural county and two 
urban districts in two geographical locations of Beijing and Shanghai, which might account 
for the lack of an observed statistical difference because of the predominance of an urban 
population. However, this study did note a statistically significant association for women (but 
not men) between depressive symptoms and insulin resistance (OR 1.58, CI 1.14-2.18; 
P=0.006) after adjusting for geographic location, residential region, age, educational level, 
smoking and drinking status, physical activity level, BMI category and comorbidity. By 
contrast, no significant association between depression comorbidity with place of residence 
was found in studies from Nigeria (p=0.80) [48] and India (OR 0.76, CI 0.44-1.34, p=0.35) 
[52]. Both studies were carried out in tertiary health care facilities, meaning that their samples 
tended to involve complicated cases, not necessarily representative of a true population 
difference. 
Mansour et al.’s [41] Iraq study derived an indicator for “social class” based on an aggregate 
score of education, occupation and income. The control group had a higher social class than 
patients with diabetes, which could be explained by the recruitment of controls from the 
medical staff of the hospital. 
Monthly income for diabetic patients was significantly and negatively correlated with 
depression scores in a study from Nigeria [40] (Pearson coefficient(r)=−0.207, p=0.003). 
Similar findings are found from research in Iran which reported that depressed patients were 
poorer (64.1% vs. 52.4% had a low income level, p<0.05) [53]. A decline in economic 
condition was significantly associated with depression among people with diabetes in a study 
from China using multiple regression analysis with adjustment for sex, age, marital status, 
educational level, income, employment, years since diagnosis of disease, and presence or 
absence of diabetes complications. (Beta 0.482, t value 2.059, p=0.041 and partial correlation 
0.132.) [54, 55]. By contrast, in India depression comorbidity was significantly associated 
with high monthly income (OR 1.22, CI 1.03-1.41, P<0.001) [52]. Finally, no significant 
association with monthly income and depression comorbidity was found in the Agbir study 
(P=0.110) from Nigeria [48]. 
Drawing conclusions about the relationship between education and depression-diabetes 
comorbidity is difficult because of the highly heterogeneous ways in which education was 
conceptualised across the different studies, in part reflecting different education systems 
between countries. The majority of studies found no significant association between the 
depression comorbidity and education level for a range of countries including Nigeria (Chi-
square 1.229, df=1, P=0.268) [48]; India [52](literate vs. illiterate, OR 1.12; CI 0.93-1.46, 
P=0.07). Studies that compared depressive and non-depressive groups also showed no 
significant difference in Nigeria (Chi-square=0.705, P=0.343) [40] and Turkey (t=1.31, 
P>0.05) [39] and (r=−0.07, P=0.49) [43]. 
The remaining four studies all suggest that lower education is associated with depression 
among people with diabetes, including: education up to secondary was significantly 
associated with depression among people with diabetes (OR 2.39; CI 1.09-5.21, P=0.029) 
[42]; and, people with diabetes who had <5 years of education were more likely to be 
depressed (OR 3.26, CI 1.57-6.80, p=0.0004) [50]. Diabetic patients in Thailand with less 
than 12 years education were significantly more likely to be depressed (OR 2.33, 1.28-4.29, 
p<0.01) [51]. Finally, depressed patients were less educated than non-depressed patients in an 
Iranian study (OR 4.20 CI 1.10-5.60; p<0.0001) [53]. 
Considering the relationship between employment, as a proxy for SES, and the comorbidity 
the findings are equally mixed. Three out of five studies found no significant association 
between depression-diabetes comorbidity and employment, including studies from Malaysia 
(Chi-square=0.429, p=0.512) [47] and Nigeria (Chi square=0.04, df=1, P=0.84) [48] and 
(Chi-square=0.087, P=0.445) [40]. Of the two studies, both from Mexico, which did find a 
relationship between employment status and depression-diabetes comorbidity both report the 
same direction: lower employment status was significantly associated with depression among 
people with diabetes [42, 50]. 
Poorer levels of social (including family) support were significantly associated with 
depression among people with diabetes studies from Thailand (OR 4.10, CI 1.78-9.53, 
p<0.01) [51] and Mexico (OR 2.79, CI 1.02-7.82, p=0.02) [50]. Depressive symptoms were 
negatively correlated with subjective social support in China (Beta −0.162, t=−3.635, 
p=<0.000 and partial correlation −0.228) [54, 55]. 
Study Limitations 
There are limitations of our search strategy that have implications for the scope of included 
evidence. Firstly, we only included items with English abstracts, meaning that we are likely 
to have excluded from the mapping substantial research evidence which may be of relevance 
for this topic. We did, however, review the type and content of these non-English items on 
the basis of their title and abstract only. Among these studies, only three studies, all from 
Latin America, appeared to be relevant to our study. A study from Brazil concludes that 
among people with diabetes, higher education, low family and individual income predispose 
to symptoms of depression [58]. A study in Mexico concludes that among people with type 2 
diabetes, significant differences between depressed and non-depressed participants were 
found in schooling, marriage type and occupation [59]. A study assessing trends in social and 
demographic inequalities in the prevalence of chronic diseases including diabetes and 
depression in Brazil [60] revealed a higher presence of chronic diseases in low socio-
economic strata. The remaining non-English studies did not provide sufficient evidence in 
their abstract for us to describe them here [61-66]. Secondly, we excluded studies that 
consider diabetes and depression in low and middle income countries that did not explicitly 
include reference to SES or one of its proxies. Therefore, there are themes that are potentially 
linked with the pathways between SES and diabetes and depression that we have not explored 
in this mapping, which may further our understanding of the relationship. A third limitation is 
methodological. As a systematic mapping, rather than a systematic review, we have not 
assessed the quality of the included studies. This means that the evidence base that we have 
identified is not necessarily all of high quality. However, as a systematic mapping we set out 
to describe the available research in order to show the gaps in the literature and, by taking an 
inclusive approach to our search, we have identified studies of research and policy relevance. 
Fourth, studies that failed to find any significant relationship between depression and diabetes 
as a comorbidity and SES, might not be published, introducing the possibility of publication 
bias. However, this possibility is diminished by the fact that we did find, but did not include 
studies in which diabetes and depression comorbidity was not the principle focus of interest 
of many of the included studies and that depression was reported as the commonest 
psychiatric disorder while diabetes was one of the many chronic disorders in the populations 
under study [56]. Fifth, assessment of SES is heterogeneous, limiting statistical 
comparability. Sixth, we included studies that used self-reports of diabetes, meaning there is 
no differentiation between type 1 and type 2 diabetes. There are further limitations linked to 
our analysis which are due to the quality and quantity of the papers found. Given the 
heterogeneity of the SES indicators and the small number of studies found we could not 
perform either a meta-analysis or a causal chain analysis. Finally, our inability to 
electronically retrieve 37 full text items, identified on the basis of our abstract search, means 
that we were unable to review some potentially relevant items. The majority of these items 
were non-peer-reviewed items such as unpublished working papers. The inability to retrieve 
some items means that we have been unable to include some potentially relevant material in 
our mapping, limiting its breadth. 
Conclusions 
Although the epidemiologic pattern of diabetes may differ according to the stage of health 
transition that a country is going through, the occurrence of depression among diabetic 
patients or independently seems to be associated with lower SES, through most of its 
variables amenable to measurement in epidemiologic studies. There exists an undiagnosed 
burden of psychiatric disorders in the population, with an increased risk among those from 
low socio-economic strata and the elderly. 
Despite the differences in study quality and heterogeneity of measured socio-economic 
variables, there have been some recurrent associations. Depression was more likely to be 
present among the elderly, and among those with low family income, the non-
professional/administrative class, those not currently employed and dependent, those living 
alone and with less social support. The relationship with education has been variable by 
country, showing a curvilinear gradient in the study from Syria [44], a significant association 
of low levels of education with depression in the studies from China [45, 49] Studies have 
also shown a higher prevalence of depression among women, [23, 44, 49, 57] which could be 
influenced by sociocultural roles of women in these countries, including responsibilities at 
work and home, single parenthood, childcare, psychological attributes, or poor social support. 
Being married was a protective factor. Severity and duration of diabetes along with other 
comorbid conditions were more likely to be associated with depression. 
More detailed research is needed to fully understand the relationship between SES and 
diabetes comorbid with depression. More generally, our mapping shows the need for research 
to address depression and diabetes together in LMICs. The size of the evidence base is out of 
step with the public health burden of this comorbidity. The proportion of the different 
components of SES contributing to this relationship might differ by the level of development 
of the economy, health systems and social support networks in these countries, the effect of 
one component mitigating the adverse effects of another. Understanding the multifaceted 
nature of socio-economic influences on health and the need to examine individual, system-
level and community level factors and their relation to health behaviours and quality of care 
would be critical to the success of efforts at prevention. 
Given the current epidemiological transition in LIMCs and with health systems struggling to 
cope with emerging non-communicable disease needs, this study highlights the strong need to 
develop further research in the field. This review indicates that there is some evidence for a 
consistent relation between SES and depression comorbid with diabetes, as well as with other 
chronic diseases. But the evidence is not strong enough to draw any sensible conclusions. 
Most of the studies found in this mapping do not suggest solutions to the issues we 
highlighted. Future research could help to determine if the associations observed are 
consistent across diverse populations, which would be important to devise successful 
interventions to reduce disease burden in the most vulnerable populations. In addition, 
efficient social support could attenuate depressive symptoms in geriatric populations, in 
communities, and in particular, among diabetic patients. 
However, we must bear in mind that social support is not always guaranteed for people with 
chronic conditions, especially in low income communities [67, 68]; and especially when the 
symptoms of uncontrolled diabetes may evoke stigma [67]. We must also consider the fact 
that the presence of depression may exacerbate negative family and social responses to 
mental distress and mental illness such as neglect and abandonment [69]. 
In several low and middle income countries where there is limited access to specialty mental 
health services, as well as an associated stigma for utilizing these services, integrating these 
services with primary care providers by offering them training and support to treat depression 
would be an effective and efficient way of resource utilization. Furthermore, LICs are limited 
in their ability to offer appropriate NCD care at the primary care level because of socio-
economic barriers, lack of insurance coverage, uncoordinated care, and shortage of 
physicians and specialist health workers. This is further limited by the lack of recognition of 
depression in many settings. Task shifting (of primary care duties from physicians to non-
physician health care providers for management of chronic diseases) has worked for the 
provision of hypertension, diabetes and cardiovascular disease care in some LICs [70, 71]. Its 
application, particularly at community level with community health nurses or lay health 
volunteers/workers may offer the best approach to reach individuals with co-morbid diabetes 
and depression. 
Endnotes 
aType 1 diabetes (previously known as insulin-dependent or childhood-onset diabetes) is 
characterized by a lack of insulin production. Type 2 diabetes (formerly called non-insulin-
dependent or adult-onset diabetes) is caused by the body’s ineffective use of insulin. It often 
results from excess body weight and physical inactivity. 
(http://www.who.int/topics/diabetes_mellitus/en/) 
bPubmed, Embase, CabDirect, Psycinfo, Web of Science, Econlit, SocINDEX, Applied 
Social Sciences Index and Abstracts (ASSIA), International Bibliography of the Social 
Sciences (IBSS), Public Affairs Information Services International (PAIS) Global Health, 
PsycExtra. 
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